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ABStrAct
Background: Percutaneous balloon mitral valvotomy is safe and 
effective in patients with severe symptomatic mitral stenosis 
with immediate and long-term results comparable to those 
of surgical intervention. This study was aimed at reporting 
the very late follow-up results of the first percutaneous bal-
loon mitral valvotomies performed at our institution and at 
identifying predictive factors of restenosis. Methods: From 
1987 to 1991, 200 consecutive patients were submitted to 
percutaneous balloon mitral valvotomy. Clinical and echocar-
diographic evaluations were performed prior to the procedure, 
48 hours after the procedure and annually thereafter. results: 
Mean age was 32 ± 12 years; 86.5% were female and 80.5% 
were in New York Heart Association functional class III or 
IV. Mean Wilkins score was 7.6 ± 1.2 and procedure success 
was observed in 87.5% (175/200) of the patients. During 
follow-up, 129 patients (74%) were followed up for 140 ± 
79 months. Restenosis was observed after the first proce-
dure in 46.5% (60/129) patients and a second percutaneous 
balloon mitral valvotomy was performed in 25 patients, a 
third one in 4 patients and a fourth one in 1 patient. The 
probability of being restenosis-free was 85% at 5 years, 60% 
at 10 years and 36% at 20 years. Left atrial diameter (P = 
0.034), and preoperative (P = 0.013) and postoperative (P 
= 0.038) transvalvar gradient were predictors of restenosis. 
conclusions: In a very late clinical follow-up, percutane-
ous balloon mitral valvotomy provided long-lasting results 
in over one-third of the patients and showed that repeated 
procedures may be performed safely in selected patients. The 
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reSuMo
evolução Muito tardia da Valvotomia Percutânea  
por Balão na estenose Mitral Grave
Introdução: A valvotomia mitral percutânea por balão é um 
procedimento seguro e eficaz em pacientes com estenose mitral 
grave sintomática selecionados, com resultados imediatos e a longo 
prazo semelhantes aos da intervenção cirúrgica. Este estudo tem 
o objetivo de descrever os resultados muito tardios das primeiras 
valvotomias mitrais percutâneas por balão realizadas em nossa 
instituição e identificar os fatores preditores de reestenose. Métodos: 
No período de 1987 a 1991, 200 pacientes consecutivos foram 
submetidos a valvotomia mitral percutânea por balão. Avaliações 
clínica e ecocardiográfica foram realizadas antes do procedimento, 
48 horas após e, então, anualmente. resultados: A média de 
idade foi de 32 + 12 anos, 86,5% eram do sexo feminino e 
80,5% encontravam-se em classe funcional III ou IV da New York 
Heart Association. A média do escore de Wilkins foi de 7,6 + 
1,2 e o sucesso do procedimento ocorreu em 87,5% (175/200) 
dos pacientes. Durante o seguimento, foram acompanhados 129 
pacientes (74%) por 140 + 79 meses. Reestenose após o primeiro 
procedimento ocorreu em 46,5% (60/129) dos pacientes, sendo 
realizada uma segunda valvotomia mitral percutânea por balão 
em 25 pacientes, uma terceira em 4 pacientes, e uma quarta 
em 1 paciente. Em cinco anos, a probabilidade livre de reeste-
nose foi de 85%, em 10 anos foi de 60% e em 20 anos, de 
36%. O diâmetro do átrio esquerdo (P = 0,034) e o gradiente 
transvalvar mitral tanto pré (P = 0,013) como pós-procedimento 
(P = 0,038) foram preditores de reestenose. conclusões: Em 
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identification of restenosis predictors is useful for patient 
 selection.
 
 
 
 
DeScrIPtorS: Mitral valve stenosis. Balloon dilation. Treat-
ment outcome.
seguimento clínico muito tardio, a valvotomia mitral percutânea 
por balão mostrou que os resultados são duradouros em mais 
de um terço dos pacientes e que a repetição do procedimento 
pode ser realizada com segurança em pacientes selecionados. 
A identificação dos preditores de reestenose é útil para guiar a 
seleção de casos para o procedimento.
DeScrItoreS: Estenose da valva mitral. Dilatação com balão.
Resultado de tratamento.
P ercutaneous mitral valvotomy with balloon catheter was first described in 1984 by Inoue et al.1 as an option for treating patients with severe mitral 
stenosis. In 1986, Al Zaibag et al.2 started using the 
double balloon technique for the transseptal route, 
and McKay et al.3 and Palacios et al.4 simplified the 
technique by performing only a septal puncture and 
subsequent dilation of the orifice to accommodate the 
passage of the two balloons.
Currently, percutaneous mitral valvotomy is con-
sidered to be the method of choice in the treatment of 
mitral stenosis.5,6 When compared with surgical mitral 
commissurotomy, mitral balloon valvotomy presents 
similar or higher success rates;7,8 the restenosis rates are 
equivalent to that of conventional surgical treatment.8
The techniques available for mitral balloon angio-
plasty include the conventional double balloon,9,10 which 
was most frequently used in the past; the Cribier metal 
commissurotome;10,11 the double balloon with single 
guidewire approach (MultiTrack);10,12,13 and the Inoue 
balloon,1,9,10 which is currently the most frequently used 
device. This technique has some advantages compared 
to the double-balloon technique, since it requires a 
shorter procedural time and is simpler. The Inoue bal-
loon procedure may be performed by a single surgeon 
and provides a more stable positioning of the balloon 
in the mitral annulus. It has been demonstrated that the 
post-valvotomy mitral valve area is similar regardless 
of the technique used.14–16
When assessing a patient with mitral stenosis, the 
following factors must be considered to indicate the 
procedure: the New York Heart Association (NYHA) 
functional class; the mitral valve area; the mitral valve 
anatomy, which is determined by the echocardiographic 
score proposed by Wilkins et al.;17 and the associated 
valve lesions. The following factors may promote better 
outcomes: young patients, valve anatomy with Wilkins 
echocardiographic score ≤ 8 points, sinus rhythm, 
absence of mitral regurgitation prior to the procedure 
and prior surgical commissurotomy.
The aim of this study was to evaluate the immedia te 
and long-term results of the first 200 percutaneous mitral 
balloon valvotomies performed at this institution. The base-
line characteristics of the patients, the restenosis predictors, 
and the need for new interventions were also assessed.
Methods
This observational, longitudinal and retrospective 
study represents a cohort of 200 consecutive patients 
with mitral stenosis submitted to percutaneous mitral 
balloon valvotomy at this institution from August 1987 
to July 1991. Early and late outcomes and predictive 
factors of restenosis were evaluated.
The patients who underwent percutaneous mitral 
valvotomy were symptomatic, with a mitral valve area 
≤ 1 cm2 and favourable anatomy according to Wilkins 
echocardiographic score.
Contraindications to the procedure included patients 
with mobile thrombus or at-risk positions (septum or mitral 
annulus) in the left atrium, associated mitral regurgitation 
≥ 2/4+ according to the classification of Sellers et al.,18 
or other valve or coronary diseases or congenital heart 
diseases associated with surgical indication.
definitions
Successful procedure: obtaining final mitral valve area 
≥ 1.5 cm2 with no regurgitation and when present, < 2/4+.
Failure: procedural interruption due to technical 
difficulties, cardiac tamponade, or severe mitral regur-
gitation that required surgical intervention.
Echocardiographic restenosis: mitral valve area 
assessed at echocardiography by planimetry and/or 
pressure half-time < 1.5 cm2 and/or loss ≥ 50% of the 
initial gain19,20 at late follow-up.
Clinical restenosis: symptom recurrence with worsen-
ing of functional class confirmed by echocardiography.
Clinical follow-up
Medical consultation 30 days after the procedure was 
performed in patients with procedural success, followed 
by annual assessments. Symptom onset during follow-
up was indicative of the need for earlier revaluations. 
Transthoracic echocardiography was recorded 48 hours 
after the procedure and annually with electrocardiograms 
and chest X-rays. The indication for a new intervention 
was based on the presence of clinical restenosis at the 
echocardiography, with observation of the same indica-
tion criteria used for the first procedure.
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statistical analysis
The Statistical Package for Social Sciences (SPSS) 
software was used for statistical analysis. Values were 
expressed as mean ± standard deviation. The variation 
of the mitral valve area mean and maximum diastolic 
gradients, the left atrial diameter, and the ejection 
fraction of the left ventricle were evaluated by Stu-
dent’s t-test. The restenosis-free probabilities during 
the study were analysed by Kaplan-Meier curves. The 
Cox regression model was used to identify predictors 
of restenosis. P-values < 0.05 were considered to be 
statistically significant. 
Results
Patient characteristics are described in Table 1. The 
mean age of the patients was 32 ± 12 years, and 173 
(86.5%) were females. A total of 39 patients (19%) 
were classified as NYHA functional class II, and 161 
patients (80.5%) were classified as functional class III 
or IV. Atrial fibrillation was present in eight patients 
(4%), and five (2.5%) underwent previous surgical 
commissurotomy. The conventional double balloon 
technique was applied in 198 patients (99%), and the 
Inoue technique was used in only two patients (1%). 
When evaluating the pre-procedural echocardiographic 
characteristics (Table 2), the mean Wilkins score was 7.6 
± 1.2 points, and only 32 patients (16%) had a score 
> 8 points. The mean left atrial diameter was 48 ± 6.2 
mm, the mean ejection fraction of the left ventricle was 
63.1 ± 7.7%, the previous mitral valve area measured 
by pressure half-time corresponded to 0.89 ± 0.23 
cm2, and the peak and mean valvular gradients were 
22.7 ± 6.4 mmHg and 13.9 ± 5.4 mmHg, respectively. 
A total of 30 (15%) patients experienced pre-procedural 
mitral regurgitation.
The procedure was successful in 175 patients (87.5%). 
Failure occurred in 24 patients (12%); in seven (3.5%) 
patients it was due to severe mitral regurgitation, and 
in 17 (8.5%) patients it was due to technical problems 
related to the learning curve (12 cases of cardiac tam-
ponade). It was not possible to perform the transseptal 
puncture in five patients (Figures 1 and 2). There was 
one death (0.5%) in the studied population. 
The echocardiographic results obtained after the 
procedure showed a final mitral valve area of 2.1 ± 
0.5 cm2, with post-procedural peak and mean diastolic 
gradients of 11.5 ± 4.8 mmHg and 4.9 ± 2.8 mmHg, 
respectively. The mean left atrial diameter was 47.6 ± 
6.4 mm. After the procedure, 70 patients experienced 
mitral regurgitation 1+/4+, and 9 patients experienced 
mitral regurgitation 2+/4+ (Table 2). 
During the follow-up, 129 patients (74%) were fol-
lowed for a mean time of 140 ± 79 months. Restenosis 
occurred in 60 patients (46.5%), a second percutaneous 
balloon mitral valvotomy was performed in 25 patients, 
a third valvotomy was performed in four patients, and 
a fourth one was performed in one patient. In the 
other patients who developed restenosis, 27 required 
surgery, and eight remained in the clinical follow-up 
(Table 3). The mitral valve area gain declined progres-
sively after the second, third, and fourth valvotomies, 
as shown in Figure 3. 
The probability that restenosis would not occur was 
85% after five years, 60% after ten years, and 36% after 
20 years, as shown in the Kaplan-Meier curve (Figure 4). 
The left atrial diameter (P = 0.034) and pre- and 
post-procedure mitral transvalvular gradients (P = 0.013 
and P = 0.038, respectively) were independent predic-
tors of restenosis, but the Wilkins score (P = 0.258) 
and the pre- and post-procedure mitral valve areas (P = 
0.5 and P = 0.054, respectively) were not independent 
predictors of restenosis (Table 4). 
disCussion
The long-term results of the treatment of mitral 
stenosis by balloon catheter are well established. Bal-
loon catheter procedures allowed up to 90% of treated 
patients to remain asymptomatic or mildly symptomatic 
over a seven-year interval,8,21 with results similar to 
surgical treatment22 but with lower costs.23 Thus, bal-
loon catheter procedures are considered to be the first 
choice in patients with favourable anatomy. 
In late follow-up studies,24,25 the study populations 
differ regarding socioeconomic, ethnic, cultural, age, 
clinical and echocardiographic characteristics and the 
aetiology of the mitral disease.26 Therefore, it is crucial 
to define therapeutics, estimate risks, and evaluate the 
prognosis to recognize the determinants of immediate 
and long-term success.
tABLe 1 
Patients’ clinical characteristics
Variable n = 200
Age, years 32 ± 12
Female gender, n (%) 173 (86.5)
Sinus rhythm, n (%) 192 (96)
NYHA FC, n (%)
II 39 (19.5)
III or IV 161 (80.5)
Pregnant patients, n (%) 14 (7)
Previous commissurotomy, n (%) 5 (2.5)
NYHA FC = New York Heart Association Functional Class.
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Patients in the present study had a mean age of 
32 years when the procedure was performed. Patients 
demonstrated a low prevalence of atrial fibrillation, 
which was similar to the prevalence found in patients 
from developing countries,27 but different from that ob-
served in developed countries, in which patients were 
older and had a higher incidence of arrhythmias.28,29 
This difference can be attributed to different aetiologies 
of mitral stenosis: rheumatic stenosis is more common 
in the Brazilian population, and degenerative stenosis 
is more prevalent in developed countries. 
Fawzy et al.22,30 demonstrated an event-free survival 
of 79% at ten years and 43% at 15 years in a population 
tABLe 2 
Pre- and Post-procedural echocardiographic characteristics 
Variable
Pre-procedural  
(n = 200)
Post-procedural  
(n = 200)
Left atrial diameter, mm 48 ± 6.2 47.6 ± 6.4
Left ventricular ejection fraction, % 63.1 ± 7.7 64.6 ± 7.9
Mitral valve area assessed by pressure half-time, cm² 0.89 ± 0.23 2.1 ± 0.5
Peak diastolic gradient, mmHg 22.7 ± 6.4 11.5 ± 4.8
Mean diastolic gradient, mmHg 13.9 ± 5.4 4.9 ± 2.8
Mitral regurgitation, n
1+/4+ 30 70
2+/4+ 0 9
3+/4+ 0 7
4+/4+ 0 7
Wilkins score, points 7.6 ± 1.2 NA
Wilkins score > 8 points, n (%) 32 (16) NA
n = number of patients; NA = not available.
Success
n = 175 (87.5%)
Restenosis
n = 60 (46.5%)
Redilation
n = 25 (19.4%)
Surgery
n = 20 (20.9%)
Clinical treatment
n = 8 (6.2%)
Follow-up
n = 129 (74%)
Loss at follow-up
n = 46 (26%)
Severe mitral regurgitation
n = 7 (3.5%)
Technical problems
n = 17 (3.5%)
Failure
n = 24 (12%)
Death after MPV
n = 1 (0.5%)
n = 200
Figure 1 – Study flow chart. n = number of patients; MPV = mitral percutaneous balloon valvotomy.
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with a mean age of 31 years; the survival was even 
higher in patients with favourable anatomic features 
(88% at ten years and 66% at 15 years). The following 
factors were related to a better prognosis: age, post-
procedure valve area, and previous valve anatomy. Age 
is a predictor of restenosis because it is associated with 
a longer time of disease evolution and, consequently, 
a higher possibility of valve degeneration.31
In Brazil, Cardoso et al.26 demonstrated an event-free 
survival of 61% at ten years in patients with a mean age 
of 35 years, with predictors of age, echocardiographic 
score, and immediate procedural outcome. The mag-
nitude of the long-term benefit is strongly influenced 
by the immediate outcome, and mitral insufficiency 
with severe regurgitation is a factor of poor prognosis 
related to the need for surgery.31,32
Other factors are related to late success, such as the 
functional class (NYHA), the mean diastolic gradient, 
and the presence of atrial fibrillation.32 However, these 
factors characterise patients with more severe anatomic 
features and a lower probability of procedural success.32 
In cases of restenosis, percutaneous mitral valvotomy 
can be performed as the first choice;32 there have been 
reports of patients submitted to up to four procedures 
with good results.33 
ConClusion
In selected cases, percutaneous balloon mitral val-
votomy demonstrates high procedural success and good 
late follow-up results, with over a third of the patients 
being restenosis-free. The identification of restenosis 
predictors is useful to select patients who will benefit 
from intervention. 
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tABLe 3 
Late results 
Variable n = 129
Follow-up, months 140 ± 79 (12 -288) 
Restenosis, n (%)  60 (46.5) 
Clinical treatment  8 (6.2) 
Redilation 25 (19.4) 
Surgery 27 (20.9) 
Severe mitral regurgitation, n (%) 7 (5.4)
Clinical treatment  1 (0.8) 
Surgery  6 (4.7)
Death at follow-up, n (%) 8 (6.2)
6%
3.5% 2.5%
87.5%
Unsuccessful transseptal 
puncture (five patients)
Success (175 patients)
Tamponade (12 patients)
Severe mitral regurgitation
(seven patients)
Figure 2 – Procedural results.
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Figure 3 – Mitral valve area after the first, second, third and fourth 
valvotomies. POST = post-procedure; PRE = pre-procedure; PMV = 
percutaneous balloon mitral valvotomy.
Figure 4 – Restenosis-free probabilities.
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